Every year, over 2,000 pharmaceutical companies choose Labcorp to advance their novel drug development. Whether you're a global pharmaceutical company expanding into India or a biopharma innovator from India aiming for global reach, Labcorp is your trusted laboratory partner to bring your therapies to patients faster.
Find out how you can advance your global drug development studies with Labcorp.
Your nonclinical development journey deserves a laboratory partner who understands your unique challenges and regional needs. With decades of experience, deep scientific capabilities and a global laboratory footprint, we’re here to accelerate your drug development program and support your commitment to deliver breakthrough medicines—across any modality or therapeutic area.
Find out how you can expedite your global nonclinical development with Labcorp.
.jpg "Cell & Gene Therapy Answers: Addressing Complex Analytical Needs with ddPCR/qPCR")
%20(1)%20copy12.png)
%20(1)%20copy.png)
Confidently navigate complex programs in an evolving global regulatory environment with a complete lab solution—from translational discovery through diagnostic commercialization—provided by the world’s largest laboratory and diagnostics company.
Whether you're focused on highly targeted development in India, such as cell and gene therapies or biologics, or seeking to define clinically relevant indicators via biomarkers, genomics testing or companion diagnostics, we can help you discover, develop and commercialize your next therapeutic.
Discover how you can accelerate your global clinical trials with Labcorp.
Map your path forward. Download a copy of the drug development journey map to gain a full view of what’s ahead.
Navigate complex programs in an evolving regulatory environment with a complete lab solution—from translational discovery through diagnostic commercialization—provided by the world’s largest laboratory and diagnostics company.
Realizing the full potential of ADCs requires deep understanding of their nuances. With extensive ADC experience and a global footprint, we provide crucial support from discovery through post-commercialization.
This webinar will cover new modalities, including gene and CAR-T cell therapy and their implementation into the bioanalytical field.
When your business goal is to exit, invest or partner on your asset, you can kick-start strategic conversations with the help of MarketPlace. Real connections are made every month. Let the next be yours.
Accelerate your molecule through critical milestones, while maximizing your asset’s value, with our uniquely integrated programmatic approach and dedicated program managers.
Enjoy global support and capacity for your nonclinical and preclinical studies with labs strategically positioned around the world.
2025 KoNECT-MOHW-MFDS International Conference
Sep. 22–24
Lotte Hotel, Seoul, South Korea
Booth 19
Oct 30 - 31
International Convention Center Jeju, Jeju Island, South Korea
CDx seminar Labcorp x KoNECT
Oct. 16
137, Mapo-daero, Mapo-gu, Seoul, South Korea
To find support for your drug development, browse our scientific publications, posters, webinars and presentations. Our scientists offer decades of experience and share world-class expertise.
From drug discovery to commercialization, Labcorp combines the experience of more than five decades of supporting biopharma companies in bringing new therapies to patients faster.
Contact us:
Sales/general enquiries:
+82-2-756-9525
Labcorp Laboratories YH
8F, 343 Hakdong-ro, Gangnam-gu, Seoul 06060
In addition to providing lab testing for healthcare and pharmaceutical companies, we also provide research testing for products in these industries.
